Search results for "ARTERIAL"

showing 10 items of 714 documents

Infarct Size Measurement by Triphenyltetrazolium Chloride StainingVersus In VivoInjection of Propidium Iodide

1997

Infarct size delineation by triphenyltetrazolium chloride (TTC) staining is dependent on sufficient reperfusion. We therefore evaluated the possibility of using propidium iodide (PI), a reagent conventionally used in flow cytometry to fluorescently stain dead cells, for infarct size analysis after short periods of reperfusion. Forty-five rabbits were subjected to either 15 min, 2 h or 4.5 h of coronary artery occlusion without reperfusion, or to 15 min, 30 min and 2 h of coronary artery occlusion followed by 30 min, 1 h and 3 h of reperfusion. Fifteen min before terminating the experiment, PI was injected into the left atrium. Patent blue violet was used to delineate the area at risk. Follo…

Pathologymedicine.medical_specialtyCell Membrane PermeabilityMyocardial InfarctionTetrazolium SaltsMyocardial ReperfusionStainFlow cytometrychemistry.chemical_compoundIn vivoOcclusionmedicineAnimalscardiovascular diseasesPropidium iodideColoring AgentsMolecular BiologyStaining and Labelingmedicine.diagnostic_testChemistrybusiness.industryMyocardiumHistologymedicine.diseaseCoronary VesselsStainingInjections Intra-ArterialRabbitsCardiology and Cardiovascular MedicineNuclear medicinebusinessReperfusion injuryPropidiumJournal of Molecular and Cellular Cardiology
researchProduct

Magnetic Resonance Imaging of Nonhepatocellular Malignancies in Chronic Liver Disease.

2021

Hepatocellular carcinoma (HCC) is the most common liver malignancy associated with chronic liver disease. Nonhepatocellular malignancies may also arise in the setting of chronic liver disease. The imaging diagnosis of non-HCC malignancies may be challenging. Non-HCC malignancies in patients with chronic liver disease most commonly include intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma, and less commonly hepatic lymphomas and metastases. On MR imaging, non-HCC malignancies often demonstrate a targetoid appearance, manifesting as rim arterial phase hyperenhancement, peripheral washout, central delayed enhancement, and peripheral restricted diffusion. When apply…

Pathologymedicine.medical_specialtyCirrhosisCarcinoma HepatocellularHepatocellular carcinomaLiver imaging reporting and data systemContrast MediaMalignancyChronic liver diseaseMetastasisMetastasismedicineHumansRadiology Nuclear Medicine and imagingneoplasmsIntrahepatic CholangiocarcinomaIntrahepatic cholangiocarcinomaCirrhosimedicine.diagnostic_testbusiness.industryLiver NeoplasmsMagnetic resonance imagingCombined hepatocellular-cholangiocarcinomamedicine.diseaseMagnetic Resonance Imagingdigestive system diseasesBile Ducts IntrahepaticBile Duct NeoplasmsHepatocellular carcinomabusinessArterial phaseMagnetic resonance imaging clinics of North America
researchProduct

Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke with and without metabolic syndrome.

2014

Objective: The aim of our study was to evaluate the associations between arterial stiffness indexes and immune-inflammatory markers in subjects with acute ischemic stroke with and without metabolic syndrome. Materials/Methods: We enrolled 130 patients with acute ischemic stroke and metabolic syndrome, 127 patients with acute ischemic stroke without metabolic syndrome and 120 control subjects without acute stroke. Applanation tonometry was used to record the augmentation index (Aix) and pulse wave velocity (PWV). We also evaluated plasma levels of C-reactive protein (CRP), Interleukin-1beta (IL-1β), tumor necrosis factor-alpha (TNF-α), Interleukin-6 (IL-6) and Interleukin-10 (IL-10), E-selec…

Pathologymedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismStroke arterial stiffness metabolic syndromeTissue plasminogen activatorVon Willebrand factorDiabetes mellitusInternal medicineInternal Medicinemedicinecardiovascular diseasesPulse wave velocityStrokePWVbiologyAixbusiness.industryResearchmedicine.diseaseArterial stiffnessStrokebiology.proteinArterial stiffnessCardiologyCytokinesMetabolic syndromebusinessPlasminogen activatormedicine.drug
researchProduct

Classification, epidemiology, risk factors, and natural history of peripheral arterial disease.

2002

Peripheral arterial disease (PAD) is a clinical condition that has often been neglected. The clinical diagnosis of PAD may be made on the basis of an accurate history by using the WHO/Rose Questionnaire or the Edinburgh Questionnaire. From a clinical point of view, PAD may be classified into four stages. The PARTNERS Programme (PAD Awareness, Risk and Treatment: NEw Resources for Survival) is a recent study based on a partnership to improve PAD care. In this population, the prevalence of patients who were PAD+/CVD- was approximately 12% in males and 15% in females; PAD+/CVD+ approximately 18% in males and 14% in females; PAD-/CVD+ 28% in males and 17% in females; and finally, patients witho…

Peripheral Vascular Diseasesmedicine.medical_specialtyeducation.field_of_studyVascular diseasebusiness.industryArterial diseaseEndocrinology Diabetes and MetabolismIncidencePopulationmedicine.diseasePeripheralbody regionsNatural historyEndocrinologyInternal medicineDiabetes mellitusEpidemiologyInternal MedicinemedicinePhysical therapyHumansbusinesseducationStrokeDiabetes, obesitymetabolism
researchProduct

Corrigendum to “Polyvascular subclinical atherosclerosis in familial hypercholesterolemia: The role of cholesterol burden and gender” [Nutr Metab Car…

2019

International audience; Background and aim: Heterozygous familial hypercholesterolemia (HeFH) is a genetic disease characterized by a heterogeneous phenotype. The assessment of cardiovascular (CV) risk is challenging for HeFH. Cholesterol burden (CB) allows to estimate the lifelong exposure to high levels of cholesterol. The aim of this study was to analyze the distribution of subclinical athero-sclerosis and the relationship between atherosclerosis and the CB in a sample of HeFH patients, focusing on sex-related differences. Methods and Results: 154 asymptomatic HeFH subjects underwent coronary-artery-calcium score (CACs) and Doppler ultrasound of carotid and femoral arteries. Yearly lipid…

Peripheral arterial atherosclerosismedicine.medical_specialtyEndocrinology Diabetes and Metabolism[SDV]Life Sciences [q-bio]Medicine (miscellaneous)030209 endocrinology & metabolismFamilial hypercholesterolemia030204 cardiovascular system & hematologyCoronary artery calcium03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineMedicineNutrition and Dieteticsbusiness.industryCholesterolmedicine.diseaseAtherosclerosisCardiovascular diseaseCardiovascular riskCalcium score3. Good healthFamilial hyper cholesterolemiaCholesterol burdenchemistrySubclinical atherosclerosisCardiologyCardiology and Cardiovascular Medicinebusiness[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Relationship between plasma endothelin-1 and aortic stiffness in hypertensive patients with chronic kidney disease

2012

Plasma endothelin aortic stiffnes chronic kidney disease arterial hypertension
researchProduct

Penetrating aortic ulcer post migration of thoracic aortic endoprosthesis: Case report

2021

Introduction Thoracic endovascular aortic repair (TEVAR) is the first treatment option for many thoracic aortic pathologies. Especially after aortic dissections, it is possible to have progression during follow-up with appearance of new lesions on arterial wall. Herein, we report a case of Penetrating Aortic Ulcer (PAU) post release of Thoracic endoprosthesis. Presentation of case A 67-years-old male with hypertension and diabetes mellitus was followed at our hospital after an emergency procedure for Type B aortic dissection (TBAD) complicated by symptomatic large infrarenal AAA and treated with a proximal TEVAR plus chimney for left subclavian artery and PETTICOAT with EVAR for abdominal a…

Post releasemedicine.medical_specialtyTEVARbusiness.industrymedicine.medical_treatmentStentTreatment optionsmedicine.diseaseAortic diseaseProsthesisSettore MED/22 - Chirurgia VascolareSurgeryPenetrating atherosclerotic ulcerPenetrating atherosclerotic ulcermedicine.arteryCase reportcardiovascular systemmedicineThoracic aortaSurgeryArterial wallComplicated aortic B dissectionbusinessMigration endoprosthesis
researchProduct

The Mode of Calcification in Atherosclerotic Lesions

1977

Calcific deposits in atherosclerotic plaques are usually considered to be an end stage of advanced atheroma formation. Postmortem studies of coronary arteries showed that pronounced atherosclerotic calcifications are strongly associated with stenosis of the involved segments and ischemic myocardial lesions (Eggen et al. 1965; McCarthy and Palmer 1974). A close correlation has also been found between calcific lesions detected by fluoroscopy or cinefluorography and clinical coronary artery disease (Oliver et al. 1964; Wartburton et al. 1968). Therefore, arterial calcification detected during life may be of important prognostic significance. Moreover, larger calcific plaques may influence the …

Postmortem studiesPathologymedicine.medical_specialtybusiness.industrymedicine.diseaseCoronary artery diseaseCoronary arteriesArterial calcificationStenosisAtheromamedicine.anatomical_structuremedicineCinefluorographybusinessCalcification
researchProduct

Postpartum Hemorrhage: Conservative Treatments

2023

Postpartum hemorrhage (PPH) is an obstetric emergency representing the first cause of obstetric mortality and a frequent cause of severe maternal morbidity. It can complicate vaginal or cesarean deliveries and accounts for 25% of all maternal deaths worldwide, as reported by the World Health Organization (WHO). Primary PPH is defined as blood loss from the genital tract of at least 500 ml after vaginal or 1000 ml following cesarean delivery within 24 h postpartum, whereas secondary PPH is defined as any significant bleeding from the birth canal occurring between 24 h and 12 weeks postnatally. Uterine atony is reported as the main cause of PPH and accounts for 75%–90% of primary PPH. When ut…

Postpartum hemorrhageUterotonic agentUterine tamponade procedureVascular ligation.Selective arterial embolizationUterine compression sutureUterine atonySettore MED/40 - Ginecologia E Ostetricia
researchProduct

Protective effect of smoking: misleading use of statistics.

2004

PsychiatryLegbusiness.industryScienceArterial Occlusive DiseasesConfounding Factors EpidemiologicsmokingvascularizationRecurrenceEnvironmental healthHumansMedicineRadiology Nuclear Medicine and imagingProspective StudiesbusinessII errorAngioplasty BalloonFollow-Up Studies
researchProduct